Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid LeukemiaClaude Preudhomme, François Guilhot, Françoise Rigal‐Huguet et al.|New England Journal of Medicine|2010Cited by 385
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemiaÉric Jourdan, Hervé Dombret, Nicolas Boissel et al.|Blood|2013Cited by 357